Investigating of Moringa Oleifera Role on Gut Microbiota Composition and Inflammation Associated with Obesity Following High Fat Diet Feeding by Elabd, Elham M. Youssef et al.
 
Open Access Maced J Med Sci electronic publication ahead of print,  
published on August 19, 2018 as https://doi.org/10.3889/oamjms.2018.313 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          1 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 
https://doi.org/10.3889/oamjms.2018.313 
eISSN: 1857-9655 
Basic Science 
 
 
  
 
Investigating of Moringa Oleifera Role on Gut Microbiota 
Composition and Inflammation Associated with Obesity 
Following High Fat Diet Feeding 
 
 
Elham M. Youssef Elabd
1*
, Safaa M. Morsy
2
, Heba A. Elmalt
2
 
 
1
Biochemistry Department, National Research Centre, Cairo, Egypt; 
2
Clinical Biochemistry Department, National Research 
Centre, Cairo, Egypt 
 
Citation: Elabd EMY, Morsy SM, Elmalt HA. 
Investigating of Moringa Oleifera Role on Gut Microbiota 
Composition and Inflammation Associated with Obesity 
Following High Fat Diet Feeding. Open Access Maced J 
Med Sci. https://doi.org/10.3889/oamjms.2018.313 
Keywords: Moringa oleifera; Obesity; Gut bacteria; 
Bifidobacterium; Lactobacillus 
*Correspondence: Elham M Youssef Elabd. 
Biochemistry Department, National Research Centre, 
Cairo, Egypt. E-mail: elhamelabd@yahoo.com 
Received: 28-May-2018; Revised: 09-Jul-2018; 
Accepted: 27-Jul-2018; Online first: 19-Aug-2018 
Copyright: © 2018 Elham M. Youssef Elabd, Safaa M. 
Morsy, Heba A. Elmalt. This is an open-access article 
distributed under the terms of the Creative Commons 
Attribution-NonCommercial 4.0 International License (CC 
BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
Abstract  
AIM: The alteration in the gut microbial community has been regarded as one of the main factors related to 
obesity and metabolic disorders. To date, little is known about Moringa oleifera as a nutritional intervention to 
modulate the microbiota imbalance associated with obesity. Therefore we aim to explore the role of aqueous 
Moringa oleiferous leaf extract on Lactobacilli and Bifidobacteria in high-fat diet-induced obesity and to investigate 
whether any restoration in the number of caecal Lactobacilli and Bifidobacteria could modulate obesity-induced 
inflammation. 
METHODS: Young Swiss albino mice were divided into three groups according to their diet. Two of them were fed 
on either high fat diet or high fat diet+aqueous extract of Moringa oleifera leaf, while the third group was fed on 
the control diet. Bacterial DNAs were isolated from the mice digesta samples for bacteria level estimation using 
Quantitative real-time polymerase chain reaction along with serum interleukin-6 and lipid profile  
RESULTS: Compared to the normal control mice, high-fat diet feeding mice showed significantly reduced 
intestinal levels of Bifidobacteria, and increased body weight, interleukin 6, and levels of Lactobacilli. Upon 
treatment with Moringa oleifera, body weight, interleukin 6, and both bacteria levels were significantly restored  
CONCLUSIONS: Our findings suggest that Moringa oliefera aqueous leaf extract may contribute towards the 
pathophysiological regulation of weight gain, inflammation associated with high-fat-induced-obesity through gut 
bacteria modulation. 
 
 
 
 
 
 
Introduction 
 
Obesity is well known to be a consequence of 
contributing factors, including hereditary, metabolic, 
behavioural and environmental factors [1] [2] [3]. Gut 
microbiota has been viewed as one of the main 
environmental factors identified with obesity and 
metabolic disorders [4] [5] [6]. Indeed the major cause 
of the development of obesity is the imbalance 
between energy intake and energy expenditure. The 
microorganisms residing in the gut influence the entire 
body metabolism by affecting such energy balance, in 
addition to other mechanisms including inflammation, 
gut barrier function, integrate peripheral and central 
nutritionally relevant information, therefore, increase 
adiposity and body weight [4] [7] [8] [9]. 
Snaz et al., and other researchers have 
supported this view and gained great insight into the 
relationship between gut bacteria and metabolic 
disorders [10]. However, certain phyla and classes of 
bacteria are associated with the improved transfer of 
calories from the diet to the host, and with alterations 
in the host metabolism of absorbed calories [6] [11] 
[12] [13] [14]. They ferment dietary polysaccharides 
and convert them into monosaccharides and short-
chain fatty acids (SCFAs). These metabolites are 
subsequently absorbed and react as a source of 
energy by the host. Moreover, SCFAs, through free 
fatty acid receptors 2 (FFAR2) and 3 (FFAR3), are 
thought to participate in the regulating of different gut 
hormones. In addition to their vital role in nutrient 
absorption and metabolism regulation they control the 
proliferation of some pathogenic bacteria existed in 
the intestinal tract [15], induce the immune system, 
contribute in the production of vitamins and enzymes 
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such as vitamin K and biotin, and in the synthesis of 
useful compounds for the mucosa and cell renewal 
[16] [17]. 
Lactobacillus (Lb) and Bifidobacteria are the 
major component of gut microbiota that are 
recognised for their basic roles in normal physiological 
processes. Moreover, they include such probiotics as 
Lactic acid bacteria (LAB), which have been proved 
benefit effects to human health. Interestingly, they 
show an alteration in diet-induced obesity via different 
mechanisms. Those beneficial intestinal Lactobacilli 
and Bifidobacteria can synthesise bioactive isomers of 
conjugated linoleic acid that have antidiabetic, anti-
atherosclerotic, immunomodulatory, and anti-obesity 
properties [18]. For the close connection between gut 
microbiota composition and metabolic disorders, more 
studies are needed to focus on how the composition 
of gut bacteria community be modified to reduce the 
risk of obesity and the associated metabolic changes.  
Currently, considerable efforts have been 
made using plants as traditional natural medicines for 
reducing body weight and healing many diseases. 
Among them is M. oleifera that belongs to the 
Moringaceae family. The medicinal values of M. 
oleifera plant parts such as roots, bark, leaves, 
flowers, fruits, and seeds have been documented to 
have antimicrobial activity [19] [20] [21] [22], 
antidiabetic [23] [24], hepatoprotective [25]. Recently, 
hypocholesterolemic and antiobesity activity of crude 
extract of M. oleifera leaf was explored [26] [27], but 
whether the anti-obesity property is related to 
modulating the gut microbiome has not been yet 
investigated; hence our study was conducted to 
investigate the effect of aqueous extract of M. oleifera 
leaves on caecal Lactobacillus and Bifidobacteria in 
experimentally induced obesity.  
 
 
Material and Methods 
 
The experimental procedures were carried out 
in biochemistry and molecular biology labs in the 
national research centre and Clinilab, Cairo, Egypt, 
following the actual law of animal protection which 
was approved by the Ethical Committee of National 
Research Center. 
Moringa oleifera leaf extract was used in this 
study after being collected from Pilbis, Sharqia 
Governorate, Egypt, and processed in the labs of 
Moringa Unit, National Research Centre. As 
powdered air dried Leaves (1 Kg) were extracted with 
(100 mL) of distilled water by boiling at a temperature 
from 80 to 100°C in reflux for 3 h to achieve an initial 
extract. The extract was then filtered with filter paper 
after cooling to room temperature. The aqueous 
extract stock solution (100 mg/mL) was stored at 4°C 
until further use according to the method used by 
Isitua et al., in 2013 [28]. 
Two types of diets were used in feeding a 
total of 45 young Swiss albino mice of either sex, (18–
20 g). A normal diet has fat content 3% of energy, and 
a high-fat diet (HFD) has fat content 20% of energy 
[29]. The fat content of the HFD was beef tallow 15% 
and corn oil 5%. The diets have a formula covering 
the nutrient requirements of the mice which were 
divided into three groups of 15 in a completely 
randomized design: Group 1, Normal control group in 
which the animals were fed on a standard chow diet 
and water ad libitum; Group 2, H.F.D (obese) group in 
which the animals were fed on H.F.D (standard chow 
diet+20% beef tallow) and water ad libitum; Group 3, 
H.F.D+M. oleifera (treated) group, in which the 
animals were fed on H.F.D and received M. oleifera 
leaf extract orally along the experiment duration (200 
mg/Kg). 
After 3 months of treatment, all mice were 
anaesthetised with ether and sacrificed. The 
abdominal cavity was opened to expose the 
gastrointestinal tract. The digest of the cecum was 
removed immediately and were stored at -80°C until 
further analyses. Blood samples were collected by 
carotid bleeding separately into sterilised dry 
centrifugation tubes and allowed to stand for 30 
minutes at 20–25°C. The clear serum was separated 
at 2500 rpm for 10 min using a centrifuge. Serum total 
cholesterol (Tc), serum high-density lipoprotein 
cholesterol (HDLc), serum triglycerides (TG), all were 
performed using Biodiagnostic Chemical Company kit 
(Egypt) according to the instructions of the suppliers. 
Serum low-density cholesterol LDL-C was 
calculated according to the equation, as follows: 
LDL-C = Total cholesterol-HDL-C-(Triglyceride/5) 
[30]. 
Serum Interleukin 6 as an inflammatory 
marker was performed using Enzyme Immunoassay 
kit (ELSA) according to the instructions of the 
suppliers (BIOS Company) Bacterial DNA was 
isolated from the digested samples using QIAamp 
DNA Stool Mini Kit according to the manufacturer’s 
protocol. The pellet was suspended in 180 µl TE 
buffer [10 mmol/L Tris-HCl (pH 8.0), 2 mmol/L EDTA], 
and the mixture was briefly mixed on a vortex mixer. 
The suspension was incubated for 30 min at 37°C, 20 
μl proteinase K and 200 μl Buffer were added. The 
pellets were mixed by vortexing and incubated at 
56°C for 30 min and then for further 15 min at 95°C. 
The supernatant was transferred to a sterile tube and 
was stored at -20°C until PCR testing (Qi gene 
protocol). Quantitative real-time PCR was carried out 
with QuantiTect SYBR Green real-time PCR detection 
system (Qi gene). Two different genus-specific primer 
sets were used in this study, (g-Bifid-F/g-Bifid-R) for 
Bifidobacterium and (Lacto-16S-F/Lacto-16S-R) for 
Lactobacillus [31]. 
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The 20-μl reaction mixture contained 10 μl of 
QuantiTectTM SYBR® green master mix, 1 μl of 25 
mmol l−1 MgCl2, 1 μl (0·2%) of BSA, 2 μl of each 
primer (5 mmol l−1) and 4 μl of template DNA 
extraction. Each PCR run included a 15-min activation 
time at 95°C as required by the instrument. The three-
step cycle included denaturing (94°C, 15 s), annealing 
(60°C, 30 s) and extension (72°C, 30 s). At the end of 
each PCR run, melting curve analysis was performed 
from 72 to 95°C for detecting nonspecific PCR product 
and primer-dimers. 
The agarose gel electrophoresis was 
performed to confirm further the specific PCR 
products. The PCR products were separated by an 
electrophoresis system at a constant voltage of 80V 
for 50 min. Then, the gel was stained with ethidium 
bromide (Sigma, USA) staining (0.5 μgml
-1
) for 5 min 
and followed by washing with distilled water for about 
30 min. Finally, the gel was visualised under UV 
transilluminator (VilberLourmat, Cedex, France) and 
the photos were taken using a gel documentation 
system (Bio-Rad Gel Doc 2000 Model Imaging 
System). 
Standards were set-up before starting 
quantitative sample DNA extraction by real-time PCR 
for quantifying the sample DNA. 
 
 
Results 
 
Our results showed the high efficiency of 
dietary fat in the significant (P < 0.05) increase of the 
blood lipid, IL-6 levels along with the significant (P < 
0.05) increase in total body weigh in mice fed on HFD 
compared to control (Table 1 & 2). 
Table 1: Statistical significant differences of lipid profile and IL-
6 in high-fat diet group after 3 months of feeding P < 0.05 
Parameters Groups N Min. Max. Mean±S.D. 
Per cent 
change 
P value 
Cholesterol 
(mg/dl) 
Control group 15 106 177 36.64 ± 23.59 100% 
0.001 
H.F.D. (Obese) group 15 200 247 221.79 ± 14.38 162.31% 
Triglycerides 
(mg/dl) 
Control group 15 65 94 82.14 ± 9.36 100% 
0.001 
H.F.D. (Obese) group 15 130 228 167.29 ± 30.30 203.65% 
HDL (mg/dl) 
Control group 15 39 80 54.29 ± 13.47 100% 
0.001 
H.F.D. (Obese) group 15 30 45 36.79 ± 5.09 67.76% 
LDL (mg/dl) 
Control group 15 46 101 70.93 ± 18.41 100% 
0.001 
H.F.D. (Obese) group 15 82 132 102.93 ± 14.95 145.12% 
IL-6 (mg/dl) 
Control group 15 2.16 7.40 3.95 ± 1.54 100% 
0.001 
H.F.D. (Obese) group 15 2.29 14.22 7.67 ± 2.72 194.23% 
 
Upon high fat-diet feeding, the amount of 
Lactobacilli in caecal digesta was significantly (P < 
0.05) higher than those in control group while the 
amount of Bifidobacteria was significantly (P < 0.05) 
lower (Table 3). 
Table 2: Statistical significant differences in total body weight 
in the obese group after 3 months of feeding P < 0.05 
Parameters Groups N Min. Max. Mean ± S.D. P value 
Total body 
weight (g) 
Control group 15 18 21 19.5 ± 1.20 
0.001 
Obese group 15 27 35 31.0 ± 1.11 
 
Table 3: Statistical significant differences of Bifidobacteria and 
Lactobacillus levels in the obese group after 3 months of 
feeding P < 0.05 
Parameters Groups N Min. Max. Mean ± S.D. 
Per cent 
Change 
P value 
Bifidobacteria 
Control group 15 7.50 11.00 9.25 ± 1.29 100% 
0.001 
Obese group 15 3.00 6.50 4.65 ± 1.11 50.27% 
Lactobacilli 
Control group 15 7.00 10.90 8.72 ± 1.06 100% 
0.001 
Obese group 15 17.5 24.00 21.08 ± 2.04 241.74% 
 
After three months of treatment with the 
aqueous extract of Moringa oleifera leaf, these mice 
showed a significant (P < 0.05) decrease in total body 
weight, Lactobacillus, blood cholesterol, triglycerides, 
LDLc and a significant (P < 0.05) increase in 
Bifidobacteria, HDLc compared to H.F.D (obese 
group). However, the decrease in IL-6 was not 
significant (Table 4, 5, 6). 
Table 4: Statistical significant differences in biochemical 
parameters in obese and Moringa treated groups after 3 
months of treatment with Moringa oleifera aqueous leaf extract 
P < 0.05 
Parameters Groups N Min. Max. Mean ± S.D. 
Per cent 
change 
P value 
Cholesterol 
(mg/dl) 
H.F.D. (Obese) group 15 200 247 221.79 ± 14.38 100% 
0.001 Moringa oleifera 
treated group 
15 150 200 170.50 ± 16.98 76.88% 
Triglycerides 
(mg/dl) 
H.F.D. (Obese) group 15 130 228 167.29 ± 30.30 100% 
0.001 Moringa oleifera 
treated group 
15 100 150 119.50 ± 15.79 71.43% 
HDL (mg/dl) 
H.F.D. (Obese) group 15 30 45 36.79 ± 5.09 100% 
0.001 Moringa oleifera 
treated group 
15 45 85 63.71 ± 11.98 173.20% 
LDL (mg/dl) 
H.F.D. (Obese) group 15 82 132 102.93 ± 14.95 100% 
0.001 Moringa oleifera 
treated group 
15 54 120 75.86 ± 23.33 73.70% 
IL-6 (mg/dl) 
H.F.D. (Obese) group 15 2.29 14 7.67 ± 2.72 100% 
0.478 Moringa oleifera 
treated group 
15 3.02 11.21 6.98 ± 2.36 90.98% 
 
 
 
Discussion 
 
The significant metabolic disturbance in sort 
of total body weight gain, and blood lipid increase, in 
our high-fat diet group mice, is obviously due to the 
positive fat balance and consequently to adipose 
mass accumulation [32] [33]. 
Table 5: Statistical significant differences of total body weight 
in obese and Moringa treated groups after 3 months of 
treatment with Moringa oleifera aqueous leaf extract P = 0.05 
Parameters Groups N Min. Max. Mean ± S.D. P value 
Total body 
weight (g) 
Obese group 15 27 35 31 ± 1.11 
0.05 Moringa oleifera 
treated group 
15 26 29 28 ± 2.3 
 
Energy balance not only depends on the diet 
but also on the microbiome as the amount of energy 
harvested is hypothesised to be influenced by the 
composition of the gut microbiota [34] [35] [36]. 
The HF diet group mice in this study had 
lower numbers of Bifidobacteria and higher numbers 
of Lactobacilli compared to control. Hildebrandt et al. 
approved in 2009 such alteration which associated 
with switching to the HF diet, a decrease in the 
Bacteroidetes level and an increase in both Firmicutes 
and Proteobacteria levels, in particular [37]. 
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Table 6: Statistical significant differences of Bifidobacteria and 
Lactobacillus levels in obese and Moringa treated groups after 
3 months of treatment with Moringa oleifera aqueous leaf 
extract P < 0.05 
Parameters Groups N Min. Max. Mean ± S.D. 
Per cent 
Change 
P value 
Bifidobacteria 
Obese group 15 3.0 6.50 4.65 ± 1.11 100% 
0.001 Moringa oleifera 
treated group 
15 6.00 9.10 7.92 ± 0.96 170.35% 
Lactobacilli 
Obese group 15 17.50 24.00 21.08 ± 2.04 100% 
0.001 Moringa oleifera 
treated group 
15 12.50 18.00 14.73 ± 1.65 69.86% 
 
Recent work that was conducted by the 
Turnbaugh team showed that specific enzymatic 
activities of obese individuals were found in Gram-
positive bacteria of the Firmicutes phylum (of which 
Lactobacillus belong to) rather than in Bacteroidetes 
[38] [39] [40]. They also described a decrease in 
Proteobacteria and Bifidobacterium spp. Upon high 
fat-diet feeding [41].Other work by Million supports 
that obesity is linked to enrichment in the 
concentrations of gut Lactobacilli, especially 
Lactobacilli reuteri [40] [42]. 
There are several possible suggested 
mechanisms as a causal link between gut microbiota 
alterations and obesity. Among them are:  
1. Increasing energy recovery from the diet by 
gut microbiota which influences host energy storage.  
2. Modulating liver lipogenesis.  
3. Regulating appetite through gut satiety 
hormones.  
4. Activating innate immunity through LPS-
Toll-like receptors [43] [44]. 
In the framework of microbiota-related 
nutrition, the clear energy imbalance could affect the 
gut barrier through changing the intestinal wall leading 
to a state of inflammation; a potential condition 
caused an increase in blood IL-6 level shown in our 
high-fat feeding mice. In 2016, Agus A et al., 
confirmed a modification of intestinal mucosa by 
dysbiosis becoming thinner and more permeable to 
pathogens and antigens with a consequent 
establishment of chronic low-grade, inflammation [45]. 
Although attempts to use natural remedies for 
weight loss has increased. Very little is known about 
the impact of Moringa on the gut microbiome which is 
a significant factor in the pathogenesis of obesity. 
Available evidence approved that leaves of M. 
oleifera possess hypolipidemic and antiobesity effects 
[19] [20] [21] [22] [23] [24] [25] [26] [27]. Whether its 
contribution is part of improving dysbiosis associated 
with diet-induced obesity is poorly understood. 
Therefore our study was conducted to explore the link 
between the gut microbiota alteration and the anti-
obesity effect of the Moringa leaf extract.  
Our results confirmed that treatment with 
Moringa oleifera leaf extract was effective in reducing 
weight gain and the consequent metabolic 
disturbance in obese group mice following H.F.D 
feeding. Apart from a reduction in body weight, 
treatment with aqueous extract of Moringa oleifera 
leaf was observed to attenuate the levels of total 
cholesterol and LDL significantly and increased the 
level of HDL level in mice fed on HFD. According to 
Farooq F et al., the hypolipidaemic effect of different 
medicinal plants has been related to their bioactive 
components [46]. A mechanism by which these 
compounds may decrease plasma cholesterol in our 
obese mice is that flavonoids that are contained in 
Moringa leaf extract may augment the activity of 
lecithin acyltransferase (LCAT), which regulates blood 
lipids. LCAT plays a key role in the incorporation of 
free cholesterol into HDL (this may increase HDL) and 
transferring it back to VLDL and LDL which are taken 
back later in liver cells [46] [47]. 
Moreover, mice in Moringa leaf extract treated 
group showed an improvement in dysbiosis by 
increasing Bifidobacteria level compared to those fed 
on HF diet. It is likely that changes in such gut 
resident microbe by Moringa treatment have a 
significant impact on another metabolic disturbance 
progression such as lipid levels and weight gain 
because Bifidobacteria can help Bacteroides degrade 
polysaccharides and inhibit exogenous cholesterol 
absorption from the small intestine [48]. 
In the last few decades, some researches 
linked the weight lowering effect of Moringa oleifera to 
the polyphenols present in their leaf extract. However, 
a more recent work added that polyphenols could 
modify the gut microbial composition, and had been 
converted by them to bioactive compounds in a two-
way relationship “polyphenols↔microbiota” which 
greatly influence host health. On the one hand, the 
first direction Polyphenol, microbiota relationship has 
been investigated by Pacheco‐Ordaz R and his team 
in very recent work in 2018. They reported that 
phenolic compounds inhibit the growth of some 
pathogenic bacteria such as Escherichia coli, while 
they promote the growth of some probiotics such as 
Lactobacillus. On the other hand, the reverse direction 
of microbiota, polyphenolic relationship, evidence 
showed that Bifidobacterium sp. and Lactobacillus sp. 
are among the few bacterial species catalyzing the 
metabolism of phenolics through some catabolic 
pathways most likely are responsible for the extensive 
breakdown of the polyphenolic structures into a series 
of low-molecular-weight phenolic metabolites that, 
being absorbable. The mechanism could be either 
through the glycan-degrading capability 
of Bacteroides, which is higher than Firmicutes or 
through the end products of colonic metabolism of 
polyphenols [50]. 
In this respect, Moringa oleifera leaf extract in 
our study could serve as a gut modulator in obesity-
induced dysbiosis, however further studies are still 
needed. 
Looking at the significant increase of 
Bifidobacteria level along with the decreased level of 
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IL-6 in Moringa oleifera treated group, predicts an 
improvement effect on the inflammatory status after 
treatment. This is in parallel with Cani et al., findings 
who used a rat obesity model to study the mechanism 
of inflammation associated with dysbiosis in obese 
mice. A significant correlation between increased 
levels of Bifidobacteria and reduced leakiness in the 
gut was observed, therefore allowing fewer LPS to 
translocate to the serum [51] [52]. 
Overall, these results support the dysbiosis 
state in response to a high-fat diet feeding and 
suggest that the response to Moringa oleifera leaf 
extract may be one potential approach to manage 
body weight and inflammation related to obesity 
through gut microbiota. 
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